Takeda makes fourth offer to buy Shire
23-04-2018
Shire to sell oncology business for $2.4bn
17-04-2018
Shire welcomes Adderall generic ruling
27-03-2018
Takeda makes waves with neurological collaboration
23-02-2018
designer491 / iStockphoto.com
Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Takeda, Shire, mergers and acquisitions, therapeutics, rare disease, M&A
